Furthermore, inhibition of the VILIP3/NFκB/Bcl-2 regulatory axis was also observed in the desloratadine-treated Huh7 and HepG2 tumor xenografts (Supplementary Fig. 7). This evidence concerns the gene HPCAL1 and neoplasm.